22 Sep 2018 | 5:52 AM
 

Natco Pharma Ltd. Share Price Live (BSE)
0

BSE Code: 524816 | NSE Symbol: NATCOPHARM
795.00
17.61
(2.27 %)
21 Sep 2018 | 03:50 PM
Change company
  • Open (Rs)
    780.00
  • Prev. close (Rs.)
    777.40
  • High (Rs.)
    795.00
  • Low (Rs.)
    755.00
  • 52W H (Rs.)
    1,061.95
  • 52W L (Rs.)
    698.85
  • Volume
    21018
  • MCap (Rs in Cr.)
    14,667.20
0
0.00
(0.00 %)
  • Open (Rs)
    0.00
  • High (Rs)
    0.00
  • Low (Rs)
    0.00
  • Prev. close(Rs)
    0.00
  • Contracts Tra.
  • Turnover (Cr.)
    N.A.
  • Open Interest
  • Open Int. chg
    0.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
37.74
Operating Margin (%)
42.49
Gross Profit Margin (%)
39.46
Net Profit Margin (%)
31.86
Total Debt/Equity
0.06
Dividend payout Ratio (Net Profit)
26.09
Earning Retention Ratio
73.87

News

09 Aug 2018 - 10:43:00-Drug firm Natco Pharma today reported a 93...
02 Jul 2018 - 13:50:00-Natco Pharma today said it has launched fixed dose combination of Sofosbuvir-Daclatasvir tablets for...
11 Jun 2018 - 00:01:00-Natco Pharma Limited has said that it has launched a generic version of Posaconazole Inject...
23 May 2018 - 16:10:00-The company reported standalone net profit of Rs 296...

Announcements

18-Sep-2018
Natco Pharma - Updates
17-Sep-2018
Natco Pharma - Shareholder Meeting / Postal Ballot-Scrutinizer`s Report
15-Sep-2018
Natco Pharma - Proceed
15-Sep-2018
Natco Pharma - Shareholder Meeting / Postal Ballot-Outcome of AGM
15-Sep-2018
Natco Pharma - Shareholders meeting

Religare Research

21 Sep 2018 | 07:00 PM
Nifty index traded extremely volatile in a broader range of roughly 600 points last week and settled...
21 Sep 2018 | 06:00 PM
Markets are witnessing correction and there’s no sign of reversal yet. Meanwhile, volatile swings an...
21 Sep 2018 | 10:57 AM
Here’s an opportunity to earn steady returns through the capital market. If you are seeking a predic...
21 Sep 2018 | 10:31 AM
• Gold rises on weaker dollar, heads for 1st weekly gain in four • Crude Oil prices pull back as Tru...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
4,00,000 90.05 31.33 -0.38
4,00,000 90.05 151.35 -0.39
4,00,000 90.05 160.06 -0.38
4,00,000 90.05 53.74 -0.39
1,60,000 35.89 81.90 -1.24

Shareholding Pattern

       
Promotors48.38%
Mutual Funds/UTI5.37%
FI/Banks0.89%
Insurance0.89%
FII24.39%
Government0.00%
Others3.78%

Peer Group

Company Intraday Graph
 Abbott India Ltd.
8,348.00(-0.86)
3280
 Sanofi India Ltd.
6,550.00(3.56)
3325
 Pfizer Ltd.
3,143.45(0.97)
3370
 Piramal Enterprises Ltd.
2,749.40(-4.81)
3356

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Natco Pharma Ltd.35.05-9.3513.60
NIFTY(S&P CNX)-427.80402.00987.85
BSE SENSEX-1,444.151,409.213,705.42
BSE 500-694.29291.23764.68

Corporate Details

Key Personal
A K S Bhujanga Rao
Director & President (R&D and Tech.)
A K S Bhujanga Rao
President & Director
D Linga Rao
Director & President (Tech. Affairs)
Key Address
Registered Office
NATCO House Road # 2 Banjara Hills,Hyderabad,Telangana

Tel:040-23547532, Fax:040-23548243

investors@natcopharma.co.in
http://www.natcopharma.co.in
Registrar Office
Venture Capital & Corporate Investments Pvt. Ltd.
Add. :No. 12-10-167 Bharat Nagar